Warning letter
Summit Insudtries Inc.: warning letter of Aug 4, 1998
FDA warning letter UCM066681 · Atlanta District Office
Key facts
| Reference number | UCM066681 |
|---|---|
| Company | Summit Insudtries Inc. |
| Subject | Drug Products / CGMP |
| Issue date | Aug 4, 1998 |
| Posted date | Aug 4, 1998 |
| Issuing office | Atlanta District Office |
| Product type | Drugs |
| CFR sections cited | 211 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: